- £332.58m
- £479.68m
- £681.90m
- 67
- 85
- 54
- 81
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 695 | 638 | 330 | 644 | 682 |
Cost of Revenue | |||||
Gross Profit | 317 | 273 | 24.2 | 258 | 273 |
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 658 | 609 | 423 | 556 | 792 |
Operating Profit | 37.4 | 28.8 | -92.9 | 87.7 | -110 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.6 | 15.4 | -107 | 74.3 | -123 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.6 | 9.4 | -96.9 | 57.4 | -95.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 29.1 | 9.8 | -72.1 | 66.2 | -95.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 29.1 | 9.8 | -72.1 | 66.2 | -95.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.174 | 0.075 | -0.228 | 0.17 | -0.032 |
Dividends per Share |